Who owns AMBRX BIOPHARMA INC?
- CUSIP Number: 641871108
Tip: Access positions for across all investors
Analyze quarterly positions in Ambrx Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ambrx Biopharma stock
Who bought or sold AMBRX BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federated Investors | 331k | $4.7M | 100% | Dec 2023 |
|
| Alliancebernstein | 258k | $3.7M | 100% | Dec 2023 |
|
| Altitude Crest Partners | 43k | $614k | 100% | Dec 2023 |
|
Who sold out of Ambrx Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Darwin Global Management | Dec 2023 | 17M | $238M |
| Cormorant Asset Management | Dec 2023 | 11M | $160M |
| Paradigm Biocapital Advisors | Dec 2023 | 4.5M | $64M |
| D. E. Shaw & Co | Dec 2023 | 4.2M | $60M |
| Nextech Invest | Dec 2023 | 3.1M | $45M |
| Balyasny Asset Management | Dec 2023 | 2.2M | $31M |
| Citadel Advisors | Dec 2023 | 2.1M | $31M |
| Logos Global Management | Dec 2023 | 2.1M | $30M |
| VR Adviser | Dec 2023 | 2.1M | $30M |
| Vanguard Group | Dec 2023 | 1.4M | $20M |
| T. Rowe Price Associates | Dec 2023 | 1.1M | $15M |
| WuXi AppTec | Dec 2023 | 1.0M | $14M |
| Millennium Management | Dec 2023 | 433k | $6.2M |
| Goldman Sachs Group | Dec 2023 | 400k | $5.7M |
| OrbiMed Advisors | Dec 2023 | 296k | $4.2M |
| Jane Street | Dec 2023 | 296k | $4.2M |
| Schonfeld Strategic Advisors | Dec 2023 | 264k | $3.8M |
| Monashee Investment Management | Dec 2023 | 208k | $3.0M |
| Barclays | Dec 2023 | 200k | $2.8M |
| TD Asset Management | Dec 2023 | 140k | $2.0M |
| Perceptive Advisors | Dec 2023 | 79k | $1.1M |
| Royal Bank of Canada | Dec 2023 | 70k | $998k |
| HealthInvest Partners AB | Dec 2023 | 58k | $824k |
| NWI Management | Dec 2023 | 54k | $764k |